Recruiting
Open Label, Safety and Efficacy Study of QRX003 Lotion in Subjects With Netherton Syndrome
NCT05789056
- Conditions
- Abnormalities, Multiple, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +10 more
- Locations
-
- Site #1 San Diego, California, United States
- Site #4 Indianapolis, Indiana, United States
- Site #5 Quincy, Massachusetts, United States
- Site #2 San Antonio, Texas, United States